venous thromboembolismVenous thromboembolism (VTE) is a blood clot, or thrombosis, that forms in a vein which may or may not break off into emboli. The classification of pulmonary embolism into low risk, sub锕巃ssive, and massive pulmonary embolism is based on hemodynamic manifestations and not ...
CrCl = creatinine clearance; DOAC = direct oral anticoagulant; DVT = deep vein thrombosis; LMWH = low-molecular-weight heparin; N/A = not applicable; PE = pulmonary embolism; UFH = unfractionated heparin; VKA = vitamin K antagonist; VTE = venous thromboembolism Data from references 3 and 4....
Thromboembolism encompasses two interrelated conditions that are part of the same spectrum, deep venous thrombosis (DVT) and pulmonary embolism (PE) (see the image below). The spectrum of disease ranges from clinically unsuspected to clinically unimporta
Venous thromboembolism: Outpatient care is noninferior to inpatient care for low-risk patients with acute pulmonary embolismThe published findings of a randomized, multinational, open-label trial have shown that outpatient care is noninferior to inpatient care for low-risk patients with pulmonary ...
embolism.Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism and is the third most common vascular disorder after heart ... PL Gross,JI Weitz - 《Clinical Pharmacology & Therapeutics》 被引量: 297发表: 2009年 加载更多研究点推荐 Venous Thromboembolism Pulmonary E...
Deep venous thrombosis (DVT) is a manifestation of venous thromboembolism (VTE). Although most DVT is occult and resolves spontaneously without complication, death from DVT-associated massive pulmonary embolism (PE) causes as many as 300,000 deaths annua
Venous thromboembolism PH: Pulmonary hypertension DVT: Deep vein thrombosis PE: Pulmonary embolism PS: Phosphatidylserine TF: Key tissue factor PEVs: Platelet-derived EVs PSGL-1: P-selectin glycoprotein ligand-1 RBC-EVs: Red blood cell-derived EVs ...
In a registry of 15,520 patients treated for symptomatic deep vein thrombosis or pulmonary embolism (PE), the 90-day mortality was 8.65% and death was attributed to PE in 1.68% of patients (19.4% of all deaths). Multivariate analysis defined five simple predictors of death from PE during ...
Barco, S., et al.Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database.Lancet Respir Med(2019). Agnelli, G. Prevention of venous thromboembolism in surgical patients.Circulation110, IV4-12 (2004)...
affected by coagulation disorders [11]; thus, they are at a high risk of thrombotic complications, ranging from widespread microvascular involvement, such as disseminated intravascular coagulation (DIC), to venous thromboembolism, arising as deep vein thrombosis (DVT) or pulmonary embolism (PE) [12,...